Page Menu

The Persistence of Intensive Glycemic Control and the Use of Fenofibrate in Diabetic Retinopaty: The ACCORD Eye Study of Type 2 Diabetes

Date Posted: Thursday, June 15, 2017
By: Emily Chew, MD, Deputy Director, Division of Epidemiology and Clinical Applications National Eye Institute, Bethesda, MD

Dr. Emily Chew Poster